| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 9.66e-06 | 12 | 72 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.59e-05 | 14 | 72 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | inositol-1,4,5-trisphosphate 5-phosphatase activity | 3.54e-04 | 8 | 72 | 2 | GO:0052658 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 5.66e-04 | 10 | 72 | 2 | GO:0004439 | |
| MousePheno | abnormal single-positive T cell number | 2.70e-05 | 84 | 59 | 5 | MP:0008081 | |
| Domain | TRP_dom | 1.14e-06 | 6 | 73 | 3 | IPR013555 | |
| Domain | TRP_2 | 1.14e-06 | 6 | 73 | 3 | PF08344 | |
| Domain | TRPC_channel | 1.98e-06 | 7 | 73 | 3 | IPR002153 | |
| Domain | TRP_channel | 9.24e-06 | 11 | 73 | 3 | IPR004729 | |
| Domain | - | 9.00e-05 | 4 | 73 | 2 | 3.90.1460.10 | |
| Domain | VPS13_C | 9.00e-05 | 4 | 73 | 2 | PF16909 | |
| Domain | GTF2I | 9.00e-05 | 4 | 73 | 2 | PS51139 | |
| Domain | SHR-BD | 9.00e-05 | 4 | 73 | 2 | IPR009543 | |
| Domain | GTF2I | 9.00e-05 | 4 | 73 | 2 | PF02946 | |
| Domain | VPS13_C | 9.00e-05 | 4 | 73 | 2 | IPR031645 | |
| Domain | GTF2I | 9.00e-05 | 4 | 73 | 2 | IPR004212 | |
| Domain | SHR-BD | 9.00e-05 | 4 | 73 | 2 | PF06650 | |
| Domain | ATG_C | 1.50e-04 | 5 | 73 | 2 | PF09333 | |
| Domain | Znf_FCS | 1.50e-04 | 5 | 73 | 2 | IPR012313 | |
| Domain | Autophagy-rel_C | 1.50e-04 | 5 | 73 | 2 | IPR015412 | |
| Domain | ZF_FCS | 2.24e-04 | 6 | 73 | 2 | PS51024 | |
| Domain | VPS13_N | 4.16e-04 | 8 | 73 | 2 | IPR026854 | |
| Domain | Chorein_N | 4.16e-04 | 8 | 73 | 2 | PF12624 | |
| Domain | IPPc | 6.64e-04 | 10 | 73 | 2 | IPR000300 | |
| Domain | IPPc | 6.64e-04 | 10 | 73 | 2 | SM00128 | |
| Domain | DOCK_C | 8.10e-04 | 11 | 73 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 8.10e-04 | 11 | 73 | 2 | IPR027007 | |
| Domain | DHR_2 | 8.10e-04 | 11 | 73 | 2 | PS51651 | |
| Domain | DHR_1 | 8.10e-04 | 11 | 73 | 2 | PS51650 | |
| Domain | DOCK-C2 | 8.10e-04 | 11 | 73 | 2 | PF14429 | |
| Domain | DHR-2 | 8.10e-04 | 11 | 73 | 2 | IPR027357 | |
| Domain | DHR-2 | 8.10e-04 | 11 | 73 | 2 | PF06920 | |
| Domain | DOCK | 8.10e-04 | 11 | 73 | 2 | IPR026791 | |
| Domain | Znf_C2H2-like | ZNF182 GTF2IRD2B ZBTB38 ZNF148 RNF125 ZNF335 SNAI2 GTF2IRD2 ZNF236 ZNF681 | 1.02e-03 | 796 | 73 | 10 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF182 GTF2IRD2B ZBTB38 ZNF148 RNF125 ZNF335 SNAI2 GTF2IRD2 ZNF236 ZNF681 | 1.14e-03 | 808 | 73 | 10 | SM00355 |
| Domain | TPR_8 | 1.17e-03 | 53 | 73 | 3 | PF13181 | |
| Domain | PI3/4_kinase_CS | 1.53e-03 | 15 | 73 | 2 | IPR018936 | |
| Domain | - | 1.75e-03 | 16 | 73 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.75e-03 | 16 | 73 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 2.21e-03 | 18 | 73 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.21e-03 | 18 | 73 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.21e-03 | 18 | 73 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.21e-03 | 18 | 73 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.21e-03 | 18 | 73 | 2 | PS00916 | |
| Domain | SH3_9 | 3.53e-03 | 78 | 73 | 3 | PF14604 | |
| Domain | SH3_1 | 3.90e-03 | 164 | 73 | 4 | PF00018 | |
| Domain | MetalloPept_cat_dom | 3.93e-03 | 81 | 73 | 3 | IPR024079 | |
| Domain | - | 3.93e-03 | 81 | 73 | 3 | 3.40.390.10 | |
| Domain | - | 4.61e-03 | 26 | 73 | 2 | 3.60.10.10 | |
| Domain | Exo_endo_phos | 4.61e-03 | 26 | 73 | 2 | PF03372 | |
| Domain | Endo/exonuclease/phosphatase | 4.96e-03 | 27 | 73 | 2 | IPR005135 | |
| Domain | ZINC_PROTEASE | 6.68e-03 | 98 | 73 | 3 | PS00142 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 4.37e-06 | 10 | 48 | 3 | M27330 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.03e-05 | 13 | 48 | 3 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.01e-05 | 16 | 48 | 3 | M26945 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 8.08e-05 | 25 | 48 | 3 | MM14511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.02e-04 | 27 | 48 | 3 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.02e-04 | 27 | 48 | 3 | MM15053 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.14e-04 | 28 | 48 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.14e-04 | 28 | 48 | 3 | M27241 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.14e-04 | 28 | 48 | 3 | M924 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 4.45e-04 | 44 | 48 | 3 | M875 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL | 7.33e-04 | 12 | 48 | 2 | MM14710 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 8.14e-04 | 54 | 48 | 3 | M3896 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL | 1.01e-03 | 14 | 48 | 2 | M27052 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 1.16e-03 | 61 | 48 | 3 | M27811 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 28526717 | ||
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 30017393 | ||
| Pubmed | TRPC channels are necessary mediators of pathologic cardiac hypertrophy. | 9.22e-08 | 5 | 74 | 3 | 20351294 | |
| Pubmed | 9.22e-08 | 5 | 74 | 3 | 21261756 | ||
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 3.22e-07 | 7 | 74 | 3 | 15757897 | |
| Pubmed | 3.22e-07 | 7 | 74 | 3 | 32350291 | ||
| Pubmed | 3.22e-07 | 7 | 74 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 3.22e-07 | 7 | 74 | 3 | 15336983 | |
| Pubmed | 3.22e-07 | 7 | 74 | 3 | 38835669 | ||
| Pubmed | 3.22e-07 | 7 | 74 | 3 | 36257322 | ||
| Pubmed | FNBP1 PHC3 AREL1 ZNF182 SYNJ1 ACAD9 INPP5B PI4KA ADAM17 DOT1L PARPBP CPLANE1 VPS13B | 4.38e-07 | 1084 | 74 | 13 | 11544199 | |
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 5.14e-07 | 8 | 74 | 3 | 12032305 | |
| Pubmed | 5.14e-07 | 8 | 74 | 3 | 25471572 | ||
| Pubmed | 5.14e-07 | 8 | 74 | 3 | 15199065 | ||
| Pubmed | 7.70e-07 | 9 | 74 | 3 | 11290752 | ||
| Pubmed | 7.70e-07 | 9 | 74 | 3 | 17480026 | ||
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 1.10e-06 | 10 | 74 | 3 | 18989690 | |
| Pubmed | 1.10e-06 | 10 | 74 | 3 | 27177420 | ||
| Pubmed | 2.60e-06 | 13 | 74 | 3 | 22051675 | ||
| Pubmed | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. | 4.47e-06 | 2 | 74 | 2 | 9930701 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22724068 | ||
| Pubmed | DC-STAMP and TACE Levels are Higher in Patients with Periodontitis. | 4.47e-06 | 2 | 74 | 2 | 32556010 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24453217 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 32140760 | ||
| Pubmed | [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels]. | 4.47e-06 | 2 | 74 | 2 | 20190513 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17706468 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25213992 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 27861908 | ||
| Pubmed | Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. | 4.47e-06 | 2 | 74 | 2 | 29700422 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23800468 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28105583 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 35051376 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23626666 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22306362 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19749484 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9368034 | ||
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 4.47e-06 | 2 | 74 | 2 | 15388857 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23529130 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33333171 | ||
| Pubmed | A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia. | 4.47e-06 | 2 | 74 | 2 | 35805125 | |
| Pubmed | N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. | 4.47e-06 | 2 | 74 | 2 | 12970363 | |
| Pubmed | PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels. | 4.47e-06 | 2 | 74 | 2 | 24470487 | |
| Pubmed | 6.15e-06 | 17 | 74 | 3 | 22411552 | ||
| Pubmed | 1.20e-05 | 21 | 74 | 3 | 30270038 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 24905090 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 28790356 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 33450211 | ||
| Pubmed | Selective association of TRPC channel subunits in rat brain synaptosomes. | 1.34e-05 | 3 | 74 | 2 | 12377790 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 32097940 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 27979597 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 15100712 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 15972814 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 36569761 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23938296 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17611684 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 10611319 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19052171 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 15358862 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 21757714 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16952553 | ||
| Pubmed | Orai proteins interact with TRPC channels and confer responsiveness to store depletion. | 1.34e-05 | 3 | 74 | 2 | 17360584 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19812035 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 35396331 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19074769 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 1.81e-05 | 24 | 74 | 3 | 33884443 | |
| Pubmed | 2.06e-05 | 25 | 74 | 3 | 16382100 | ||
| Pubmed | 2.61e-05 | 27 | 74 | 3 | 16460286 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 15498460 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 20728215 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 17823943 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 23229069 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 19260825 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 22899722 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 12356946 | ||
| Pubmed | The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone. | 2.67e-05 | 4 | 74 | 2 | 23832809 | |
| Pubmed | The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing. | 2.67e-05 | 4 | 74 | 2 | 26520460 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 22566504 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 21328569 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 28636132 | ||
| Pubmed | Formation of novel TRPC channels by complex subunit interactions in embryonic brain. | 4.45e-05 | 5 | 74 | 2 | 12857742 | |
| Pubmed | Enhanced capacitative calcium entry and TRPC channel gene expression in human LES smooth muscle. | 4.45e-05 | 5 | 74 | 2 | 12736151 | |
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 30452936 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 22027011 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 24449818 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 18436303 | ||
| Pubmed | TRPC3 channels are required for synaptic transmission and motor coordination. | 4.45e-05 | 5 | 74 | 2 | 18701065 | |
| Pubmed | 4.82e-05 | 33 | 74 | 3 | 19834762 | ||
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 11390792 | ||
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 18676862 | ||
| Pubmed | trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. | 6.66e-05 | 6 | 74 | 2 | 8646775 | |
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 25347706 | ||
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 32414784 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 7.39e-05 | 38 | 74 | 3 | 30786075 | |
| Pubmed | Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. | 9.31e-05 | 7 | 74 | 2 | 23233529 | |
| Pubmed | 9.31e-05 | 7 | 74 | 2 | 38109525 | ||
| Pubmed | 9.31e-05 | 7 | 74 | 2 | 10373452 | ||
| Pubmed | Identification of Annexin A4 as a hepatopancreas factor involved in liver cell survival. | 9.31e-05 | 7 | 74 | 2 | 25176043 | |
| Pubmed | Pkd1 and Wnt5a genetically interact to control lymphatic vascular morphogenesis in mice. | 9.31e-05 | 7 | 74 | 2 | 34174014 | |
| Pubmed | 1.05e-04 | 686 | 74 | 8 | 29987050 | ||
| Pubmed | 1.15e-04 | 44 | 74 | 3 | 19322198 | ||
| Interaction | TRPC7 interactions | 8.68e-07 | 6 | 72 | 3 | int:TRPC7 | |
| GeneFamily | Transient receptor potential cation channels | 6.59e-05 | 28 | 51 | 3 | 249 | |
| GeneFamily | CD molecules|C-type lectin domain family|Killer cell lectin like receptors | 5.06e-04 | 12 | 51 | 2 | 621 | |
| GeneFamily | Phosphoinositide phosphatases | 3.67e-03 | 32 | 51 | 2 | 1079 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.83e-03 | 718 | 51 | 7 | 28 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.96e-03 | 41 | 51 | 2 | 1298 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 6.40e-03 | 134 | 51 | 3 | 861 | |
| Coexpression | GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN | 9.07e-07 | 184 | 74 | 7 | M3281 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | FNBP1 ZBTB38 NAA15 ZNF148 VPS13C ITSN2 DOCK10 ATM PARPBP CPLANE1 | 1.53e-05 | 656 | 74 | 10 | M18979 |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 2.14e-05 | 199 | 74 | 6 | M1746 | |
| Coexpression | GSE27786_LSK_VS_NEUTROPHIL_DN | 2.20e-05 | 200 | 74 | 6 | M4761 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 2.20e-05 | 200 | 74 | 6 | M7324 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 2.20e-05 | 200 | 74 | 6 | MM1033 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.50e-08 | 194 | 74 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.64e-07 | 194 | 74 | 6 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.90e-07 | 195 | 74 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 178 | 74 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.43e-05 | 185 | 74 | 5 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.50e-05 | 187 | 74 | 5 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.54e-05 | 188 | 74 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-05 | 189 | 74 | 5 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.58e-05 | 189 | 74 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 193 | 74 | 5 | 64a37dae3d631713b06d94691f5dcdb200dfef5e | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.93e-05 | 197 | 74 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.93e-05 | 197 | 74 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.93e-05 | 197 | 74 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.98e-05 | 198 | 74 | 5 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.98e-05 | 198 | 74 | 5 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.98e-05 | 198 | 74 | 5 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.98e-05 | 198 | 74 | 5 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 5.80e-05 | 126 | 74 | 4 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 146 | 74 | 4 | c0e1836845c083bf9d88a620da27acbfdea9fb20 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 152 | 74 | 4 | fa03262e2853b7d35ef8cdbb652930abad90563c | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.29e-04 | 155 | 74 | 4 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 155 | 74 | 4 | 550e7e7e52829244ead829e5be010bfdc71e2ba5 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 74 | 4 | 398f162e8a75c6cb5c3e4d1832e98d386e1f222b | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 74 | 4 | 12aaab0291035f578e2433efd169ae72f393a5a5 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.53e-04 | 162 | 74 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 165 | 74 | 4 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 165 | 74 | 4 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 168 | 74 | 4 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 170 | 74 | 4 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 170 | 74 | 4 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 1.88e-04 | 171 | 74 | 4 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 172 | 74 | 4 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 172 | 74 | 4 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.97e-04 | 173 | 74 | 4 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 176 | 74 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 177 | 74 | 4 | 36da06ca9577cdb7c7b5114e604f6546b9765c08 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 178 | 74 | 4 | 9423e209de94d26e96117581c95dc069850225d3 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 179 | 74 | 4 | 1b079d80f789473701c781f3431ad306e9766797 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.34e-04 | 181 | 74 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 182 | 74 | 4 | e5f62ce9b9e0d28627617f7cbc81026f8442e402 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 182 | 74 | 4 | 0e16824c721d8b7d527157cb65feec909f6b974c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 183 | 74 | 4 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-04 | 184 | 74 | 4 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-04 | 185 | 74 | 4 | 6e7fefdd65d30abaffb26b92b0d04e1630d262ad | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 2.54e-04 | 185 | 74 | 4 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-04 | 186 | 74 | 4 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-04 | 186 | 74 | 4 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-04 | 186 | 74 | 4 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.65e-04 | 187 | 74 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.76e-04 | 189 | 74 | 4 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-04 | 189 | 74 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-04 | 189 | 74 | 4 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-04 | 189 | 74 | 4 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-04 | 189 | 74 | 4 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-04 | 190 | 74 | 4 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.81e-04 | 190 | 74 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-04 | 190 | 74 | 4 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | PSB-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.81e-04 | 190 | 74 | 4 | e1b5d76edd4c1b95c0a7b94284a65043ab895e67 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 191 | 74 | 4 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 191 | 74 | 4 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 191 | 74 | 4 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.93e-04 | 192 | 74 | 4 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.93e-04 | 192 | 74 | 4 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-04 | 192 | 74 | 4 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-04 | 192 | 74 | 4 | 63d1b3efe93e5ff939278ebe40bacb38218ea09b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-04 | 192 | 74 | 4 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 193 | 74 | 4 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.99e-04 | 193 | 74 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.99e-04 | 193 | 74 | 4 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 193 | 74 | 4 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-04 | 193 | 74 | 4 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.99e-04 | 193 | 74 | 4 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.05e-04 | 194 | 74 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-04 | 194 | 74 | 4 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.05e-04 | 194 | 74 | 4 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-04 | 194 | 74 | 4 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 3.05e-04 | 194 | 74 | 4 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 195 | 74 | 4 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 195 | 74 | 4 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-04 | 195 | 74 | 4 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 195 | 74 | 4 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 196 | 74 | 4 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.17e-04 | 196 | 74 | 4 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 3.17e-04 | 196 | 74 | 4 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.17e-04 | 196 | 74 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-04 | 196 | 74 | 4 | bbdc92ec2e95ed7d782df0c72d94f9a9d9439bf0 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 196 | 74 | 4 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 3.17e-04 | 196 | 74 | 4 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.23e-04 | 197 | 74 | 4 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-04 | 197 | 74 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 3.29e-04 | 198 | 74 | 4 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.29e-04 | 198 | 74 | 4 | b2c8d5956f8449df4b69fb1b30632253440f815e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.35e-04 | 199 | 74 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.35e-04 | 199 | 74 | 4 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Severe-B_intermediate-6|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.35e-04 | 199 | 74 | 4 | bf6ebb63ab361d9d1946225894d7be433e9befab | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.42e-04 | 200 | 74 | 4 | f268cb1bb047e88913a828614b0a77871f5f8814 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.42e-04 | 200 | 74 | 4 | 5ff9ac97ef970b3b74ebb07f62a0a1f4176a10b4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.42e-04 | 200 | 74 | 4 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.42e-04 | 200 | 74 | 4 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.42e-04 | 200 | 74 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Disease | nicotine dependence (implicated_via_orthology) | 3.15e-06 | 12 | 73 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.81e-05 | 3 | 73 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Peripheral T-Cell Lymphoma | 2.68e-04 | 10 | 73 | 2 | C0079774 | |
| Disease | cancer (implicated_via_orthology) | 5.41e-04 | 268 | 73 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Autosomal recessive primary microcephaly | 6.21e-04 | 15 | 73 | 2 | cv:C3711387 | |
| Disease | response to methotrexate | 7.08e-04 | 16 | 73 | 2 | GO_0031427 | |
| Disease | intellectual disability (implicated_via_orthology) | 8.63e-04 | 75 | 73 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 1.00e-03 | 19 | 73 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | body weight | HHLA2 CNNM2 ZBTB38 RASGRF1 ADAMTS3 VPS13C INPP5B DOT1L PCDH7 DNAH14 | 1.05e-03 | 1261 | 73 | 10 | EFO_0004338 |
| Disease | feeling nervous measurement | 1.33e-03 | 87 | 73 | 3 | EFO_0009597 | |
| Disease | cortex volume change measurement, age at assessment | 2.19e-03 | 28 | 73 | 2 | EFO_0008007, EFO_0021500 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MTAEYACTRKQFNKR | 321 | Q9H845 | |
| MSASYQEAKCKLKSY | 541 | Q96M93 | |
| KSFESMQRLCDKYNR | 66 | Q8TEK3 | |
| KCMRNKSAYFAEKLY | 241 | P09525 | |
| LKYRQKFNTLDKSMS | 246 | Q9NZM3 | |
| KMKQTLIRSQFACTY | 421 | Q9NWS1 | |
| NMTFQYRKLKCMTDS | 101 | Q6ZTZ1 | |
| TYSSKETCFSKKKLM | 71 | Q3ZCV2 | |
| CKRNSTSIYFKMEND | 166 | P19256 | |
| EFAAMYSAKQLKLSC | 881 | Q9P2D0 | |
| SKYMNFRVRACNKAV | 271 | Q9BXM9 | |
| KEMQNLSFQDCYSSK | 101 | P30084 | |
| EYSCQTNNKYSKQMR | 1046 | O60245 | |
| SCMSQNASLLKVYSK | 126 | P26718 | |
| MKYEKRNTNSFLICS | 146 | Q9UM44 | |
| CVKKDYSNFMASLNL | 1131 | P42356 | |
| MASTSACYKLFREKQ | 491 | Q9Y2J8 | |
| KRFCTMSCAKRYNVS | 801 | Q8NDX5 | |
| MSCAKRYNVSCSKKF | 806 | Q8NDX5 | |
| DRFINSKCAKYMLKA | 441 | Q9BXJ9 | |
| YKSELFQKAKSLMQC | 741 | Q13315 | |
| QYTKYGCRRKSDNKM | 866 | O15072 | |
| GYMTLSFKNRCKSKQ | 6 | D3W0D1 | |
| KSNRQFCSKLGKYRM | 541 | Q96BY6 | |
| MSCTVNVLNFYKEKK | 1221 | Q9H7D0 | |
| FCKRDSNFMRSKKKS | 1041 | Q9H799 | |
| KYTSCKAFISNLNEM | 66 | Q96RU3 | |
| SKYQMSSFSNKEDRC | 416 | Q5T9S5 | |
| TQKMYELKTKLRCSY | 236 | Q5T197 | |
| NSSMYRESCKGKLSK | 276 | P35575 | |
| YEKAKKTYMQACKRS | 1016 | Q5T0N1 | |
| EMCYQRTKNFDKLSF | 691 | P53621 | |
| IEDKRMYECKSQKFN | 116 | Q8N4A0 | |
| FYMLSMKNKACRKNL | 71 | Q7Z4B0 | |
| IFSKTSCSYCTMAKK | 71 | Q9NS18 | |
| YKSKVCFILNNDMSE | 606 | O15033 | |
| IKSQIMFYNDCVKSF | 1016 | Q0VDD8 | |
| SLSKREFCFQNVKYM | 671 | P32019 | |
| LFSIMKLSKTKYCSQ | 921 | Q86UP8 | |
| LFSIMKLSKTKYCSQ | 921 | Q6EKJ0 | |
| KNFTVLNFKRRKMCY | 181 | P34925 | |
| SYRKKQLDKSMCSQF | 51 | C9J302 | |
| NFPSSMYCDNRKLKT | 71 | Q99983 | |
| SLCKYFEDSRNMKTL | 436 | Q9GZY0 | |
| IYCVAKFMETRKQSN | 296 | Q5M8T2 | |
| SASSKVLKSMCENFY | 511 | O43426 | |
| DFCSRYIACLKTKMN | 141 | P55347 | |
| NMLKTYFSDVKFNRC | 601 | Q92786 | |
| YQCKNCSKTFSRMSL | 241 | O43623 | |
| FSKTMNSCKVLQIRY | 636 | Q13972 | |
| SENKKTRYCNGLKMF | 16 | Q9Y6L6 | |
| YTKQAFLLSSCLKKM | 361 | Q8N9S9 | |
| NNKMFSNCSKQSIYK | 446 | P78536 | |
| RKMEKSKSYYLCTSL | 181 | Q9H8M5 | |
| NECEKAFSQKSYLML | 461 | P17025 | |
| MKDALQTCQKYRKKY | 196 | Q5VTQ0 | |
| ATDVAKRMKSEYKNC | 86 | Q96EQ8 | |
| SFKEAALRAYKKQMA | 971 | Q8NB66 | |
| FKEKTKCMINQYSNY | 611 | P78562 | |
| KAYLKKISMQCFDFT | 1471 | Q709C8 | |
| KRFCSMTCAKRYNVS | 816 | P78364 | |
| YSCMALSKSKSQEQK | 1851 | Q7Z7G8 | |
| TTQSKIFQCDKYMKI | 136 | Q96N22 | |
| KAFKCQYCMKSFSTS | 536 | Q9UL36 | |
| MKCKRAPYKSYRNSS | 571 | Q8NAP3 | |
| STNYDDAMQFLKKKR | 461 | Q9UQR1 | |
| NDYKKLSMQCKDFVV | 316 | Q9Y210 | |
| KCKMCQYRSSTKATL | 246 | Q9H4Z2 | |
| NLSKCDFTQMSQYFK | 296 | P11387 | |
| MDKMYRNLYKKACSS | 466 | Q9NWH7 | |
| KALNYSQKCAFLMAS | 706 | A6NCI4 | |
| KEFKNDYRKLSMQCK | 241 | Q13507 | |
| ETEFKNDYRKLSMQC | 256 | Q9HCX4 | |
| KNSSACKDYLIEAMK | 266 | O95198 | |
| FSSRKYLKKEMNSFQ | 16 | P20592 | |
| KENYEKTKAKSMNYC | 636 | P20929 |